NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
+26.24%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$139M
AUM Growth
+$139M
Cap. Flow
-$1.99M
Cap. Flow %
-1.43%
Top 10 Hldgs %
97.44%
Holding
15
New
1
Increased
1
Reduced
4
Closed
1

Top Buys

1
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$1.32M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
$477K

Top Sells

1
KPTI icon
Karyopharm Therapeutics
KPTI
$1.5M
2
SAGE
Sage Therapeutics
SAGE
$1.12M
3
DVAX icon
Dynavax Technologies
DVAX
$572K
4
ADAP
Adaptimmune Therapeutics
ADAP
$508K
5
DERM
Dermira, Inc.
DERM
$87.9K

Sector Composition

1 Healthcare 94.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.53B
$25.5M 18.33% 784,159 – –
ARAV
2
DELISTED
Aravive, Inc. Common Stock
ARAV
$25M 17.98% 2,039,223 – –
PDSB icon
3
PDS Biotechnology
PDSB
$57.8M
$24.4M 17.57% 2,344,868 – –
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$17.3M 12.46% 1,377,497 – –
DMTX
5
DELISTED
Dimension Therapeutics, Inc
DMTX
$16.5M 11.85% 2,059,283 – –
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$7.57M 5.45% 230,954 +40,148 +21% +$1.32M
DERM
7
DELISTED
Dermira, Inc.
DERM
$6.56M 4.72% 193,944 -2,600 -1% -$87.9K
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$6.11M 4.4% 132,674 -24,284 -15% -$1.12M
DVAX icon
9
Dynavax Technologies
DVAX
$1.19B
$4.2M 3.02% 400,381 -54,500 -12% -$572K
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.31M 1.66% 2,590,673 – –
VTGN icon
11
VistaGen Therapeutics
VTGN
$102M
$1.49M 1.07% 352,950 – –
TRIL
12
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.19M 0.86% 80,759 – –
RCKT icon
13
Rocket Pharmaceuticals
RCKT
$354M
$477K 0.34% +50,300 New +$477K
ADAP
14
Adaptimmune Therapeutics
ADAP
$15.6M
$388K 0.28% 55,008 -72,033 -57% -$508K
KPTI icon
15
Karyopharm Therapeutics
KPTI
$61.7M
– – -222,947 Closed -$1.5M